Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05971836 · ClinicalTrials.gov registry record
The Molecular Basis of Inherited Reproductive Disorders
A clinical trial of Hypogonadotropic Hypogonadism and Kallmann Syndrome, sponsored by Stephanie B. Seminara, MD.
- Recruiting
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT05971836 is a study of Hypogonadotropic Hypogonadism and Kallmann Syndrome that is actively recruiting participants, run by Stephanie B. Seminara, MD. The registered enrollment target is 600 participants, above the 27-participant average among 6 other Hypogonadotropic Hypogonadism trials with a reported enrollment target (2122% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05971836, a study of Hypogonadotropic Hypogonadism and Kallmann Syndrome, is actively recruiting participants, sponsored by Stephanie B. Seminara, MD.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn more about the genes that control puberty and reproduction in humans.
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2026-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05971836
The ClinicalTrials.gov registry entry for NCT05971836 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 27-participant average among 6 other Hypogonadotropic Hypogonadism trials with a reported enrollment target (2122% higher). The listed sponsor is Stephanie B. Seminara, MD, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hypogonadotropic Hypogonadism appearing as the primary indexed condition, and to 0 interventions.
NCT05971836 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05971836 about?
NCT05971836 is a clinical study titled "The Molecular Basis of Inherited Reproductive Disorders". The goal of this study is to learn more about the genes that control puberty and reproduction in humans.
What is the current status of trial NCT05971836?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2021-01-21. Estimated completion is 2026-03.
What conditions does trial NCT05971836 study?
This clinical trial studies the following conditions: Hypogonadotropic Hypogonadism, Kallmann Syndrome, Reproductive Disorder, Delayed Puberty.
Who is sponsoring clinical trial NCT05971836?
This trial is sponsored by Stephanie B. Seminara, MD, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05971836 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypogonadotropic Hypogonadism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.
RECRUITING
-
Kisspeptin Administration Subcutaneously to Patients With IHH
RECRUITING · Phase 2
-
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
RECRUITING · Phase 2
-
Effect of Intranasal Insulin on LH Concentrations in Man
COMPLETED · Phase 1
-
Opioid Antagonism in Hypogonadotropic Hypogonadism
COMPLETED · Phase 1
-
Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.